23 related articles for article (PubMed ID: 9879289)
1. Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumour.
Sharma S; Saha K; Shinghal RN; Malik GB
Cancer Immunol Immunother; 1991; 33(3):198-202. PubMed ID: 2044083
[TBL] [Abstract][Full Text] [Related]
2. A Case of Esophageal Cancer With Markedly Elevated Soluble Interleukin-2 Receptor: A Potential of Soluble Interleukin-2 Receptor as a Biomarker.
Seto N; Miura K; Jin L; Nakahara M
Cureus; 2024 Apr; 16(4):e57477. PubMed ID: 38699096
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
[TBL] [Abstract][Full Text] [Related]
4. The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.
Bien E; Rapala M; Krawczyk M; Balcerska A
J Cancer Res Clin Oncol; 2010 Feb; 136(2):293-305. PubMed ID: 19693535
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of biomarkers in head and neck cancer.
Koch WM
Curr Oncol Rep; 1999; 1(2):129-37. PubMed ID: 11122809
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptor in cancer.
Murakami S
Front Biosci; 2004 Sep; 9():3085-90. PubMed ID: 15353339
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma.
Hsu MM; Chen YJ; Chang YL; Ko JY; Sheen TS
Asian Pac J Allergy Immunol; 1995 Jun; 13(1):1-4. PubMed ID: 7488337
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma.
Lai KN; Ho S; Leung JC; Tsao SY
Cancer; 1991 Apr; 67(8):2180-5. PubMed ID: 1848475
[TBL] [Abstract][Full Text] [Related]
9. [Relation between the expression of sIL-2R and the relapse in patients with acute lymphoblastic leukemia].
Liu J; Wu DS; Zhang S; Yan CH; Zhou Y; Zhang YD; Qi ZH
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):249-51. PubMed ID: 15968312
[TBL] [Abstract][Full Text] [Related]
10. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
Bilińska M; Frydecka I; Podemski R
Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
[TBL] [Abstract][Full Text] [Related]
12. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer.
Wu LJ; Chen KY; Chi KH; Chen SY; Liang MJ; Shiau CY; Wang LW; Liu YM; Chow KC; Yen SH
Jpn J Clin Oncol; 1998 Dec; 28(12):729-32. PubMed ID: 9879289
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
